ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Price, Quote & AI Analysis
Live PRQR stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for ProQR Therapeutics N.V. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for ProQR Therapeutics N.V. Ordinary Shares (PRQR), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
ProQR Therapeutics N.V. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
ProQR Therapeutics N.V. Ordinary Shares Overview
Company information
Company Overview
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
ProQR Therapeutics N.V. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...